Botaneco Announces Resignation of Director Michael Stangel, Grant of Option and Issuance of Common Shares

QUEBEC CITY, May 22, 2012 /CNW/ - Botaneco Corp. ("Botaneco" or the "Corporation") (TSX-V:BOT), a health science company focused on natural ingredients in the personal care industry, announces that Michael Stangel, former President and Chief Executive Officer of the Corporation, has tendered his resignation from the Board of Directors.

As part of the termination arrangement with Mr. Stangel with respect to the termination of his employment in November 2011, the Corporation has agreed to issue to Mr. Stangel 235,294 Common Shares of the Corporation (the "Common Shares") at an issue price of $0.085 per Common Share and 200,000 stock options. The stock options have an exercise price of $0.10 and are governed by the Stock Option Plan of the Corporation. Therefore, the stock options will cease to be exercisable 90 days after the resignation of Mr. Stangel from the Board of Directors. The issuance of the Common Shares was approved by the TSX Venture Exchange Inc.

About Botaneco Corp.

Botaneco Corp. specializes in personal care, food and nutraceutical ingredients. We are committed to developing groundbreaking ingredients based on our patented technologies, and offering multifunctional, tangible and documented benefits to formulators and consumers alike.  Botaneco is a global developer and marketer of innovative technologies that help manufacturers meet the consumers growing demand for natural, environmentally friendly, personal healthcare products.  A competitive advantage to Botaneco's patented technology over traditional products in the 'green sector' is the ability to significantly enhance the performance and versatility of these skin and hair care products.  The company has also been awarded the Canadian Agri-Food Award of Excellence for its flaxseed technology marketed in the natural food industry.  Botaneco holds patents for its HydresiaÒ Oleosome, VegelatumÒ Gel, DermylexÒ Whey Protein and Flaxseed De-hulling technology.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. 

Murray Bruce
CFO
Botaneco Corp.
[phone]
[email protected]